Skip to main content

José Alegre Martin

Institutions of which they are part

Rheumatology
Vall Hebron Institut de Recerca

José Alegre Martin

Institutions of which they are part

Rheumatology
Vall Hebron Institut de Recerca

Projects

Ensayo clínico, aleatorizado, controlado, paralelo, para evlauar la eficacia de dos técnicas de acupuntura validad en salud: Somatoacupuntura versus Auriculopuntura, como tratamiento en los pacientes diagnosticados con Síndrome de Fatiga Crónica

IP: -
Collaborators: José Alegre Martin
Funding agency: Col·legi Oficial d'Infermers/es de Barcelona
Funding: 2420
Reference: COIB-2725-12
Duration: 01/01/2013 - 31/12/2014

Ensayo clínico, aleatorizado, controlado, paralelo, doble ciego, para evaluar eficacia-seguridad de alteplasa vs uroquinasa intrapleurales como tratamiento del derrame paraneumónico complicado complejo y empiema

IP: Maria Carmen Aleman Llanso
Collaborators: Ana Vázquez Suárez, J. Bruno Montoro Ronsano, José Alegre Martin, Tomás Fernández de Sevilla Ribosa, María Deu Martín, Jordi Andreu Soriano, Teresa Soriano Sánchez, Pilar Suñe Martin, Eva Ruiz Ruiz
Funding agency: Instituto de Salud Carlos III
Funding: 82885
Reference: EC07/90479
Duration: 01/11/2007 - 30/06/2011

Registro de base poblacional de los pacientes afectos del síndrome de fatiga crónica

IP: José Alegre Martin
Collaborators: Eva Ruiz Ruiz
Funding agency: Fundación Invest. Médica Mutua Madrileña
Funding: 38000
Reference: FMMA/14/2006
Duration: 04/05/2007 - 01/10/2010

Repercusión funcional de la alteración neurovegetativa en los pacientes con el síndrome de fatiga crónica

IP: José Alegre Martin
Collaborators: Montserrat Duran Taberna, Eva Ruiz Ruiz
Funding agency: Instituto de Salud Carlos III
Funding: 51170
Reference: PI050200
Duration: 01/01/2006 - 31/12/2008

Related news

The new therapeutic strategy aims at maintaining the efficacy of thalidomide while avoiding its main systemic adverse effects.

The event, held as part of World Lupus Day, incorporated the perspective of people living with the disease to address the challenges associated with lupus.

The global biopharmaceutical company UCB has acquired the data and clinical knowledge business of IMIDomics, a spin-off of the Vall d’Hebron Institute of Research (VHIR).

Related professionals

Antonia Pijuan Domenech

Antonia Pijuan Domenech

Predoctoral researcher
Cardiovascular Diseases
Read more
Manuel Ramirez Valencia

Manuel Ramirez Valencia

Predoctoral researcher
Spine Research Unit
Read more
Pablo Castillo Sánchez

Pablo Castillo Sánchez

Research technician
Neurodegenerative Diseases
Read more
Angel García Jiménez

Angel García Jiménez

Biomedical Research in Gynaecology
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.